|
Q2 2019
|
23 |
120,064 |
ICPT, INSM, BOLD, NBIX
|
13F-HR
|
8/14/2019 |
000164634319000007 |
|
Q1 2019
|
24 |
82,402 |
BOLD, HRTX, INSM, IMMU
|
13F-HR
|
5/15/2019 |
000164634319000006 |
|
Q4 2018
|
23 |
242,621 |
XBI puts, BMRN calls, NVS, TEVA calls
|
13F-HR
|
2/14/2019 |
000164634319000004 |
|
Q3 2018
|
56 |
521,826 |
XBI puts, EXEL, AGN, IMMU
|
13F-HR
|
11/14/2018 |
000164634318000008 |
|
Q2 2018
|
45 |
645,892 |
XBI puts, AGN, IMMU, EXEL
|
13F-HR
|
8/14/2018 |
000164634318000007 |
|
Q1 2018
|
40 |
607,263 |
XBI puts, AGN, BMY, BMRN
|
13F-HR
|
5/15/2018 |
000164634318000004 |
|
Q4 2017
|
39 |
542,415 |
XBI puts, AGN, SHPG, MYL
|
13F-HR
|
2/14/2018 |
000164634318000002 |
|
Q3 2017
|
38 |
388,737 |
XBI puts, SGEN, TEVA puts, CLVSQ
|
13F-HR
|
11/14/2017 |
000164634317000008 |
|
Q2 2017
|
41 |
229,510 |
SHPG, AZN calls, ALXN, GSK
|
13F-HR
|
8/14/2017 |
000164634317000006 |
|
Q1 2017
|
36 |
195,967 |
PFE, SHPG, AZN calls, CELG
|
13F-HR
|
5/15/2017 |
000164634317000004 |
|
Q4 2016
|
39 |
170,598 |
SHPG, NVS, CELG, ALXN
|
13F-HR
|
2/14/2017 |
000164634317000002 |
|
Q3 2016
|
33 |
162,735 |
SPDR S&P Biotech ETF puts, PFE, GSK, SHPG
|
13F-HR
|
11/14/2016 |
000164634316000010 |
|
Q2 2016
|
35 |
115,486 |
PFE, GSK, SHPG, SGEN
|
13F-HR
|
8/15/2016 |
000164634316000008 |
|
Q1 2016
|
32 |
96,539 |
CELG, SHPG, PFE, AGN
|
13F-HR
|
5/13/2016 |
000114036116064987 |
|
Q4 2015
|
45 |
70,492 |
PFE, BMY, CELG, MRK
|
13F-HR
|
2/16/2016 |
000114036116052655 |